| Literature DB >> 21586172 |
Wai Fung Chong1, Yew Yoong Ding, Bee Hoon Heng.
Abstract
BACKGROUND: The use of comorbidities in risk adjustment for health outcomes research is frequently necessary to explain some of the observed variations. Medical charts reviews to obtain information on comorbidities is laborious. Increasingly, electronic health care databases have provided an alternative for health services researchers to obtain comorbidity information. However, the rates obtained from databases may be either over- or under-reported. This study aims to (a) quantify the agreement between administrative data and medical charts review across a set of comorbidities; and (b) examine the factors associated with under- or over-reporting of comorbidities by administrative data.Entities:
Mesh:
Year: 2011 PMID: 21586172 PMCID: PMC3112394 DOI: 10.1186/1472-6963-11-105
Source DB: PubMed Journal: BMC Health Serv Res ISSN: 1472-6963 Impact factor: 2.655
Figure 1Study flow diagram.
Patient characteristics (n = 3471)
| Characteristic | |
|---|---|
| Mean age, years (SD) | 77.3 (10.8) |
| Male gender, n (%) | 1885 (54.3) |
| Nursing home residents, n (%) | 675 (19.5) |
| Ethnic group, n (%) | |
| Chinese | 2721 (78.4) |
| Malay | 373 (10.7) |
| Indian | 225 (6.5) |
| Others | 152 (4.4) |
| No. of Elixhauser comorbid conditions, n (%) | |
| 0 | 258 (7.4) |
| 1-2 | 1544 (44.5) |
| 3-4 | 1263 (36.4) |
| 5-6 | 367 (10.6) |
| 7-8 | 34 (1.0) |
| 9-10 | 5 (0.1) |
| >10 | 0 (0) |
| Hospital admission in the previous 90 days, n (%) | 440 (12.7) |
| CURB* score, n (%) | |
| 0 | 1544 (44.5) |
| 1 | 1399 (40.3) |
| ≥2 | 528 (15.2) |
| Mean length of stay, days (SD) | 9.8 (12.4) |
| Death in hospital, n (%) | 693 (20.0) |
*CURB = Constructed from 4 "core" adverse prognostic features: Confusion, Urea, Respiratory rate, Blood pressure [35]
Prevalence of comorbidities and agreement between data derived from medical charts and administrative data (n = 3471)
| Comorbidities | Medical charts No. (%) | Administrative data No. (%) | Kappa (95% CI) |
|---|---|---|---|
| Diabetes, uncomplicated | 996 (28.7) | 900 (25.9) | 0.78 (0.77 - 0.80) |
| Metastatic cancer | 116 (3.3) | 112 (3.2) | 0.71 (0.70 - 0.73) |
| Diabetes, complicated | 203 (5.8) | 256 (7.4) | 0.69 (0.67 - 0.71) |
| Chronic pulmonary disease | 561 (16.2) | 417 (12.0) | 0.54 (0.53 - 0.56) |
| Lymphoma | 20 (0.6) | 17 (0.5) | 0.54 (0.52 - 0.56) |
| Alcohol abuse | 33 (1.0) | 23 (0.7) | 0.53 (0.52 - 0.55) |
| Hypertension | 2068 (59.6) | 1190 (34.3) | 0.45 (0.44 - 0.47) |
| Peripheral vascular disorders | 199 (5.7) | 94 (2.7) | 0.44 (0.43 - 0.46) |
| Liver disease | 109 (3.1) | 57 (1.6) | 0.43 (0.42 - 0.45) |
| Congestive heart failure | 469 (13.5) | 252 (7.3) | 0.40 (0.39 - 0.42) |
| RA/Collagen vascular disease | 43 (1.2) | 12 (0.3) | 0.36 (0.35 - 0.37) |
| Cardiac arrhythmias | 489 (14.1) | 222 (6.4) | 0.34 (0.33 - 0.36) |
| Coagulopathy | 118 (3.4) | 271 (7.8) | 0.33 (0.32 - 0.35) |
| Hypothyroidism | 118 (3.4) | 40 (1.2) | 0.33 (0.32 - 0.35) |
| Other neurological disorders | 426 (12.3) | 142 (4.1) | 0.33 (0.31 - 0.34) |
| Solid tumor without metastasis | 363 (10.5) | 200 (5.8) | 0.32 (0.30 - 0.34) |
| Fluid and electrolyte disorders | 942 (27.1) | 712 (20.5) | 0.32 (0.30 - 0.33) |
| Deficiency anemias | 474 (13.7) | 704 (20.3) | 0.28 (0.26 - 0.29) |
| Valvular disease | 98 (2.8) | 38 (1.1) | 0.21 (0.19 - 0.22) |
| Pulmonary circulation disorders | 44 (1.3) | 16 (0.5) | 0.20 (0.18 - 0.21) |
| Psychoses | 97 (2.8) | 13 (0.4) | 0.14 (0.13 - 0.15) |
| Weight loss | 18 (0.5) | 82 (2.4) | 0.13 (0.12 - 0.15) |
| Depression | 319 (9.2) | 33 (1.0) | 0.08 (0.07 - 0.09) |
| Renal failure | 447 (12.9) | 24 (0.7) | 0.06 (0.05 - 0.07) |
| Peptic ulcer disease | 174 (5.0) | 16 (0.5) | 0.05 (0.04 - 0.05) |
| Blood loss anemia | 3 (0.1) | 57 (1.6) | 0.03 (0.02 - 0.04) |
| Paralysis | 16 (0.5) | 128 (3.7) | 0.01 (-0.01 - 0.02) |
Sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) of comorbidities (n = 3471)
| Comorbidities | Sensitivity | Specificity | Positive Predictive Value | Negative Predictive Value | ||||
|---|---|---|---|---|---|---|---|---|
| % | 95% CI | % | 95% CI | % | 95% CI | % | 95% CI | |
| Diabetes, complicated | 80.3 | 74.2 - 85.5 | 97.2 | 96.5 - 97.7 | 63.7 | 57.5 - 69.6 | 98.8 | 98.3 - 99.1 |
| Diabetes, uncomplicated | 80.1 | 77.5 - 82.6 | 95.9 | 95.0 - 96.6 | 88.7 | 86.4 - 90.7 | 92.3 | 91.2 - 93.3 |
| Metastatic cancer | 70.7 | 61.5 - 78.8 | 99.1 | 98.7 - 99.4 | 73.2 | 64.0 - 78.8 | 99.0 | 98.6 - 99.3 |
| Coagulopathy | 60.2 | 50.8 - 69.1 | 94.0 | 93.2 - 94.8 | 26.2 | 21.1 - 31.9 | 98.5 | 98.1 - 98.9 |
| Hypertension | 54.3 | 52.1 - 56.5 | 95.2 | 94.0 - 96.3 | 94.4 | 92.9 - 95.6 | 58.6 | 56.5 - 60.6 |
| Chronic pulmonary disease | 52.8 | 48.5 - 57.0 | 95.8 | 95.1 - 96.5 | 71.0 | 66.4 - 75.3 | 91.3 | 90.3 - 92.3 |
| Lymphoma | 50.0 | 27.2 - 72.8 | 99.8 | 99.6 - 99.9 | 58.8 | 32.9 - 81.6 | 99.7 | 99.5 - 99.9 |
| Deficiency anemias | 49.2 | 44.6 - 53.8 | 84.3 | 82.9 - 85.6 | 33.1 | 29.6 - 36.7 | 91.3 | 90.2 - 92.3 |
| Alcohol abuse | 45.5 | 28.1 - 63.7 | 99.8 | 99.5 - 99.9 | 65.2 | 42.7 - 83.6 | 99.5 | 99.2 - 99.7 |
| Fluid and electrolyte disorders | 41.8 | 38.7 - 45.1 | 87.4 | 86.1 - 88.7 | 55.3 | 51.6 - 59.0 | 80.1 | 78.6 - 81.6 |
| Weight loss | 38.9 | 17.3 - 64.3 | 97.8 | 97.3 - 98.3 | 8.5 | 3.5 - 16.8 | 99.7 | 99.4 - 99.8 |
| Congestive heart failure | 35.4 | 31.1 - 39.9 | 97.1 | 96.5 - 97.7 | 65.9 | 59.7 - 71.7 | 90.6 | 89.5 - 91.6 |
| Peripheral vascular disorders | 34.2 | 27.6 - 41.2 | 99.2 | 98.8 - 99.5 | 72.3 | 62.2 - 81.1 | 96.1 | 95.4 - 96.8 |
| Liver disease | 33.9 | 25.2 - 43.6 | 99.4 | 99.1 - 99.6 | 64.9 | 51.1 - 77.1 | 97.9 | 97.4 - 98.4 |
| Blood loss anemia | 33.3 | 0.8 - 90.6 | 98.4 | 97.9 - 98.8 | 1.8 | 0.0 - 9.4 | 99.9 | 99.8 - >99.9 |
| Cardiac arrhythmias | 29.0 | 25.1 - 33.3 | 97.3 | 96.7 - 97.9 | 64.0 | 57.3 - 70.3 | 89.3 | 88.2 - 90.4 |
| Solid tumor without metastasis | 28.7 | 24.1 - 33.6 | 96.9 | 96.2 - 97.5 | 52.0 | 44.8 - 59.1 | 92.1 | 91.1 - 93.0 |
| Other neurological disorders | 24.7 | 20.6 - 29.0 | 98.8 | 98.3 - 99.1 | 73.9 | 65.9 - 80.9 | 90.4 | 89.3 - 91.3 |
| Rheumatoid Arthritis/Collagen vascular disease | 23.3 | 11.8 - 38.6 | 99.9 | 99.8 - >99.9 | 83.3 | 51.6 - 97.9 | 99.1 | 98.7 - 99.3 |
| Hypothyroidism | 22.9 | 15.7 - 31.5 | 99.6 | 99.3 - 99.8 | 67.5 | 50.9 - 81.4 | 97.4 | 96.8 - 97.9 |
| Valvular disease | 15.3 | 8.8 - 24.0 | 99.3 | 99.0 - 99.6 | 39.5 | 24.0 - 56.6 | 97.6 | 97.0 - 98.1 |
| Pulmonary circulation disorders | 13.6 | 5.2 - 27.4 | 99.7 | 99.5 - 99.9 | 37.5 | 15.2 - 64.6 | 98.9 | 98.5 - 99.2 |
| Psychoses | 8.3 | 3.6 - 15.6 | 99.9 | 99.7 - >99.9 | 61.5 | 31.6 - 86.1 | 97.4 | 96.8 - 97.9 |
| Paralysis | 6.3 | 0.2 - 30.2 | 96.3 | 95.6 - 96.9 | 0.8 | 0.0 - 4.3 | 99.6 | 99.3 - 99.8 |
| Depression | 5.0 | 2.9 - 8.0 | 99.5 | 99.1 - 99.7 | 48.5 | 30.8 - 66.5 | 91.2 | 90.2 - 92.1 |
| Renal failure | 3.8 | 2.2 - 6.0 | 99.8 | 99.5 - 99.9 | 70.8 | 48.9 - 87.4 | 87.5 | 86.4 - 88.6 |
| Peptic ulcer disease | 2.9 | 0.9 - 6.6 | 99.7 | 99.4 - 99.8 | 31.3 | 11.0 - 58.7 | 95.1 | 94.3 - 95.8 |
Multinomial regression to determine factors that are associated with over-reporting and under-reporting of comorbidity (n = 100659)
| Explanatory variable | Odds Ratio (95% confidence interval) | |
|---|---|---|
| Over-reporting vs. same-reporting | Under-reporting vs. same-reporting | |
| Age (per year) | 1.003 (0.999 - 1.007) | 1.010 (1.007 - 1.013)* |
| Male gender | 1.009 (0.924 - 1.103) | 1.057 (0.997 - 1.121) |
| Hospital admission in the previous 90 days | 0.974 (0.879 - 1.079) | 1.108 (1.039 - 1.182)* |
| Number of co-morbid conditions | 1.013 (0.984 - 1.044) | 1.443 (1.418 - 1.469)* |
| CURB score: | ||
| 0 (reference) | 1.000 | 1.000 |
| 1 | 1.352 (1.219 - 1.500)* | 1.109 (1.035 - 1.187)* |
| ≥ 2 | 1.488 (1.303 - 1.700)* | 1.058 (0.966 - 1.158) |
| Length of hospital stay (per day) | 1.013 (1.011 - 1.015)* | 1.000 (0.997 - 1.002) |
| Death in hospital | 1.028 (1.118 - 1.379)* | 1.028 (0.958 - 1.103) |
* Statistical significance at p-value < 0.05
Factors associated with over-reporting of 10 selected comorbidities
| Age | Previous admission | No of comorbidities | Length of stay | Severity of illness | Death | |
|---|---|---|---|---|---|---|
| Metastatic cancer | + | + | + | |||
| Solid tumour without mestastases | + | + | ||||
| Chronic heart failure | + | + | + | + | ||
| Renal failure | + | + | ||||
| Chronic pulmonary disease | + | |||||
| Peripheral vascular disease | + | + | ||||
| Hypertension | + | |||||
| DM uncomplicated | + | + | ||||
| DM complicated | + | |||||
| Deficiency anaemia | + | + | + | |||
+: denotes a positive association that is statistically significant (p-value < 0.05)
Factors associated with under-reporting of 10 selected comorbidities
| Age | Previous admission | Male | No of comorbidities | Length of stay | Severity of illness | |
|---|---|---|---|---|---|---|
| Solid tumour without mestastases | + | + | ||||
| Liver disease | + | + | + | |||
| Chronic heart failure | + | + | + | + | ||
| Renal failure | + | + | + | + | + | |
| Chronic pulmonary disease | + | + | ||||
| Peripheral vascular disease | + | + | ||||
| Hypertension | + | + | ||||
| DM uncomplicated | + | + | + | |||
| DM complicated | + | |||||
| Deficiency anaemia | + | + | ||||
+: denotes a positive association that is statistically significant (p-value < 0.05)